Cerebrovasculature & ApoE

Apolipoprotein E (APOE) is a protein involved in fat metabolism and associated with the pathogenesis of neurodegenerative and cardiovascular diseases. This feed focuses on the role of this protein in cerebrovasculature and cerebrovascular dysfunction.

August 6, 2020
Review
Open Access

Cardiovascular Manifestations and Complications of Pheochromocytomas and Paragangliomas

Journal of Clinical Medicine
Shams Y-Hassan, Henrik Falhammar
August 7, 2020

The evolution of the CTO-PCI landscape in Belgium and Luxembourg: a four-year appraisal

Acta Cardiologica
Ward EertmansBWGCTO Investigators
August 3, 2020

APOE and metabolic dysfunction in Alzheimer's disease

International Review of Neurobiology
Lance A Johnson
August 2, 2020

Reliability and availability of granger causality density in localization of Rolandic focus in BECTS

Brain Imaging and Behavior
Xi-Jian DaiYongjun Wang
August 1, 2020
Open Access

The protective effect of pneumococcal vaccination on cardiovascular disease in adults: A systematic review and meta-analysis

International Journal of Infectious Diseases : IJID : Official Publication of the International Society for Infectious Diseases
Fawziah MarraNirma Vadlamudi
August 4, 2020

Amyloidogenic Nanoplaques in Cerebrospinal Fluid: Relationship to Amyloid Brain Uptake and Clinical Alzheimer's Disease in a Memory Clinic Cohort

Journal of Alzheimer's Disease : JAD
Mari AksnesAnne-Brita Knapskog
August 5, 2020
Open Access

Decline of emergency admissions for cardiovascular and cerebrovascular events after the outbreak of COVID-19

Clinical Research in Cardiology : Official Journal of the German Cardiac Society
Viktoria SchwarzSebastian Ewen
August 2, 2020

Neuroimaging and radiation exposure in pregnancy

Handbook of Clinical Neurology
Annika AndersonRiley Bove
August 1, 2020

Radial access for neurointervention: room set-up and technique for diagnostic angiography

Journal of Neurointerventional Surgery
Stephanie H Chen, Eric C Peterson
August 5, 2020
Open Access

Conformational selection vs. induced fit: insights into the binding mechanisms of p38α MAP Kinase inhibitors

Chemical Communications : Chem Comm
Patrick RoserMalte Drescher
August 3, 2020
Review

Neuropathological assessment of the Alzheimer spectrum

Journal of Neural Transmission
Kurt A Jellinger
August 5, 2020
Open Access

Neurological comorbidity and severity of COVID-19

Journal of Neurology
Alberto RomagnoloLeonardo Lopiano
August 1, 2020
Open Access

Default Mode Network Analysis of APOE Genotype in Cognitively Unimpaired Subjects Based on Persistent Homology

Frontiers in Aging Neuroscience
Liqun KuangAlzheimer’s Disease Neuroimaging Initiative
August 7, 2020

Changes in lipid biology during ovarian development in farmed beluga sturgeon, Huso huso L

American Journal of Physiology. Regulatory, Integrative and Comparative Physiology
Sobhan R AkhavanP Mark Lokman

Sign up to follow this feed and discover related papers.

Related Feeds

ALS

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.

ALS & FTD: TDP-43

ALS shares with a considerable proportion of FTD cases the same neuropathological substrate, namely, inclusions of abnormally phosphorylated protein tdp-43 (ptdp-43). Here are the latest discoveries pertaining to ptdp-43 and these diseases.

ALS - Pathogenic Mechanisms

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

ALS - Phenotypes

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating phenotypes associated with this genetically heterogeneous disorder.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

ALS: Prions

Prions are misfolded proteins which characterize several fatal neurodegenerative diseases. Prion-like mechanisms are associated with the pathogenesis of Amyotrophic Lateral Sclerosis (ALS). Here are the latest discoveries pertaining to this disease.

ALS: Stress Granules

Amyotrophic Lateral Sclerosis (ALS) is a neurodegenerative disease characterized by cytoplasmic protein aggregates within motor neurons. TDP-43 is an ALS-linked protein that is known to regulate splicing and storage of specific mRNAs into stress granules, which have been implicated in formation of ALS protein aggregates. Here is the latest research.

ALS: Therapies

Amyotrophic Lateral Sclerosis (ALS), also known as motor neuron disease, is associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS therapies here.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

ATG proteins

The discovery of autophagy-related ('ATG') proteins in the 1990s greatly advanced the mechanistic understanding of autophagy and clarified the fact that autophagy serves important roles in various biological processes.

© 2020 Meta ULC. All rights reserved
/feed-previews/cerebrovasculature-apoe/ed962e7a-78ae-48ed-9942-acf07feafaad